Dark

Check out our Dark Pool Levels

CMLF
CM Life Sciences, Inc. Class A Common Stock
stock NASDAQ

Inactive

Jul 22, 2021

11.60USD-7.051%(-0.88)491,902

Pre-market

0.00USD-100.000%(-12.48)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jul 22, 2021

09:16AM EDT Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly GlobeNewswire Inc

Jul 2, 2021

12:15PM EDT CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination Business Wire

Jun 18, 2021

11:17AM EDT CM Life Sciences Option Alert: Sep 17 $17.5 Calls at the Ask: 2500 @ $0.85 vs 4174 OI; Ref=$13.8489 Benzinga

May 5, 2021

06:10AM EDT CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance Business Wire

Mar 16, 2021

01:01PM EDT 10 SPACs Owned By Cathie Wood's Ark Funds Benzinga

Feb 24, 2021

05:34PM EST CM LIFE SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CM Life Sciences - CMLF Business Wire

Feb 17, 2021

07:02PM EST Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Feb. 17, 2021: ABBV, VEEV, SGFY, EXAS, CMLF, BFLY, TSLA, SHOP, NTDOY, IRDM, FATE, BEAM, TDY, RAVN, KMTUY Benzinga

Feb 12, 2021

09:01PM EST SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM PR Newswire

01:59PM EST Moore Kuehn Encourages SYNC, NEBC, FRX, and CMLF Investors to Contact Law Firm PR Newswire

Feb 11, 2021

08:00PM EST Rigrodsky Law, P.A. announces that it is investigating CM Life Sciences, Inc. (CM Life Sciences) (NASDAQ GS: CMLF) regarding possible breaches of fiduciary duties and other violations of law related to CM Life Sciences agreement to merge with Sema4. GlobeNewswire Inc

04:15PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates CM Life Sciences, Inc. PR Newswire

Feb 10, 2021

07:09AM EST Sema4 to Combine with CM Life Sciences to Accelerate Growth Benzinga

07:00AM EST Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth Business Wire

Share